- ¥910bn
- ¥897bn
- ¥500bn
Brief: Sysmex Corp - Senior Managing Director Kaoru Asano To Become President, Effective On April 1
Sysmex says Japan approves blood test for Alzheimer's marker
Brief: Sysmex- Receives Manufacturing And Marketing Approval In Japan For An Assay Kit To Identify Amyloid Beta Accumulation In The Brain, A Cause Of Alzheimer's Disease, Using A Small Amount Of Blood
Table: Sysmex -6-MTH group results (IFRS)
Table: Sysmex -Q1 group results (IFRS)
Table: Sysmex -2021/22 group results (IFRS)
Table: Sysmex -2021/22 parent results
Brief: Shanghai Labway Clinical's Unit To Buy Equipment And Instruments
Table: Sysmex -9-MTH group results (IFRS)
Table: Sysmex -6-MTH group results (IFRS)
Table: Sysmex -Q1 group results (IFRS)
Table: Sysmex -2020/21 parent results
Table: Sysmex -2020/21 group results (IFRS)
Japanese shares gain on cyclicals boost, selling in some heavyweights weighs
Table: Sysmex -9-MTH group results (IFRS)
Brief: Oxford Immunotec Global Signs Agreement With Riken Genesis Co
Table: Sysmex -6-MTH group results (IFRS)
Brief: Sysmex America Signs Exclusive Agreement To Distribute And Service Siemens Healthineers Automated Urine Chemistry Analyzer
Table: Sysmex -Q1 group results (IFRS)